Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7465 p169
18 August 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
Retention fee 2008


10,000 protest online over fee increase

More than 10,000 people have supported an online petition against the proposed 50 per cent increase in Royal Pharmaceutical Society retention fees.

Launched on 31 July 2007, the petition gained the support of 10,092 people, including pharmacists, pharmacy technicians and some members of the public before it closed on 14 August. Some so-called signatories were anonymous and it was possible for false entries to be made.

However, having said last week that it would not take the petition into account in its consultation on the planned increase, the Society has now agreed to include it. Ann Lewis, the Society’s Secretary and Registrar said this week: “The Society has asked that, to ensure that the petition is taken into account by the Council, it should be submitted to the fees consultation e-mail address, or to the Secretary and Registrar’s Office by 3 October 2007. This will ensure that the petition is analysed as part of the consultation process and that the analysis will reflect the complete picture.”

Suffolk pharmacist Mark Cheeseman, who instigated the petition, said that the electronic petition could be printed out and submitted to the Society. Mr Cheeseman said that he hoped the petition and the consultation would be used to highlight pharmacists’ concerns about the planned increase. Commenting on the level of support elicited by the petition, he said: “I was staggered by the number. I thought I’d be lucky to get 100 signatures.”

Guild view The Guild of Healthcare Pharmacists is to submit a response to the Society’s fees consultation exercise on behalf of its 4,000 members.

This week the guild said that it expected any organisation facing financial difficulties to review and make significant financial and organisational changes to make itself viable. This review should include the cost of running the Society’s Council. The guild added that many NHS organisations had gone through such exercises in 2006–07, but that there was little evidence of such a review within the Society.

Back to Top


©The Pharmaceutical Journal